203 related articles for article (PubMed ID: 25937073)
1. Global analysis of chromosome 1 genes among patients with lung adenocarcinoma, squamous carcinoma, large-cell carcinoma, small-cell carcinoma, or non-cancer.
Zhang Y; Wang H; Wang J; Bao L; Wang L; Huo J; Wang X
Cancer Metastasis Rev; 2015 Jun; 34(2):249-64. PubMed ID: 25937073
[TBL] [Abstract][Full Text] [Related]
2. Variations of chromosome 2 gene expressions among patients with lung cancer or non-cancer.
Bao L; Zhang Y; Wang J; Wang H; Dong N; Su X; Xu M; Wang X
Cell Biol Toxicol; 2016 Oct; 32(5):419-35. PubMed ID: 27301951
[TBL] [Abstract][Full Text] [Related]
3. Genome analyses identify the genetic modification of lung cancer subtypes.
Zhang Y; Wang DC; Shi L; Zhu B; Min Z; Jin J
Semin Cancer Biol; 2017 Feb; 42():20-30. PubMed ID: 27845189
[TBL] [Abstract][Full Text] [Related]
4. A global view of regulatory networks in lung cancer: An approach to understand homogeneity and heterogeneity.
Lu J; Wang W; Xu M; Li Y; Chen C; Wang X
Semin Cancer Biol; 2017 Feb; 42():31-38. PubMed ID: 27894849
[TBL] [Abstract][Full Text] [Related]
5. Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.
Faruki H; Mayhew GM; Serody JS; Hayes DN; Perou CM; Lai-Goldman M
J Thorac Oncol; 2017 Jun; 12(6):943-953. PubMed ID: 28341226
[TBL] [Abstract][Full Text] [Related]
6. Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients.
Fathi Z; Mousavi SAJ; Roudi R; Ghazi F
PLoS One; 2018; 13(7):e0200633. PubMed ID: 30048458
[TBL] [Abstract][Full Text] [Related]
7. Different impact of IL10 haplotype on prognosis in lung squamous cell carcinoma and adenocarcinoma.
Wang YC; Sung WW; Wang L; Cheng YW; Chen CY; Wu TC; Shieh SH; Lee H
Anticancer Res; 2013 Jun; 33(6):2729-35. PubMed ID: 23749933
[TBL] [Abstract][Full Text] [Related]
8. Global analyses of subtype- or stage-specific genes on chromosome 7 in patients with lung cancer.
Wang J; Zhang Y; Wan H; Dong N; Bao L; Sun X; Xu M; Wang X
Cancer Metastasis Rev; 2015 Jun; 34(2):333-45. PubMed ID: 25951983
[TBL] [Abstract][Full Text] [Related]
9. Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.
Yeo MK; Choi SY; Seong IO; Suh KS; Kim JM; Kim KH
Hum Pathol; 2017 Oct; 68():103-111. PubMed ID: 28851662
[TBL] [Abstract][Full Text] [Related]
10. Nuclear and mitochondrial DNAs microsatellite instability and mitochondrial DNA copy number in adenocarcinoma and squamous cell carcinoma of lung: a pilot study.
Lee DH; Lee JH; Kim DK; Keum DY
APMIS; 2015 Dec; 123(12):1048-54. PubMed ID: 26547371
[TBL] [Abstract][Full Text] [Related]
11. Notch Signaling Components: Diverging Prognostic Indicators in Lung Adenocarcinoma.
Liu ZY; Wu T; Li Q; Wang MC; Jing L; Ruan ZP; Yao Y; Nan KJ; Guo H
Medicine (Baltimore); 2016 May; 95(20):e3715. PubMed ID: 27196489
[TBL] [Abstract][Full Text] [Related]
12. Combined analysis identifies six genes correlated with augmented malignancy from non-small cell to small cell lung cancer.
Zhang C; Min L; Zhang L; Ma Y; Yang Y; Shou C
Tumour Biol; 2016 Feb; 37(2):2193-207. PubMed ID: 26349752
[TBL] [Abstract][Full Text] [Related]
13. Expression of phosphatase and tensin homolog and programmed cell death ligand 1 in adenosquamous carcinoma of the lung.
Hlaing AM; Furusato B; Udo E; Kitamura Y; Souda M; Masutani M; Fukuoka J
Biochem Biophys Res Commun; 2018 Sep; 503(4):2764-2769. PubMed ID: 30100056
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
[TBL] [Abstract][Full Text] [Related]
15. Genomic Copy Number Signatures Uncovered a Genetically Distinct Group from Adenocarcinoma and Squamous Cell Carcinoma in Non-Small Cell Lung Cancer.
Lee E; Moon JW; Wang X; Kim C; Li S; Shin BK; Jung W; Kim HK; Kim HK; Lee JY
Hum Pathol; 2015 Aug; 46(8):1111-20. PubMed ID: 26003479
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of role of Notch3 signaling pathway in human lung cancer cells.
Hassan WA; Yoshida R; Kudoh S; Motooka Y; Ito T
J Cancer Res Clin Oncol; 2016 May; 142(5):981-93. PubMed ID: 26838758
[TBL] [Abstract][Full Text] [Related]
17. Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays.
Dmitriev AA; Kashuba VI; Haraldson K; Senchenko VN; Pavlova TV; Kudryavtseva AV; Anedchenko EA; Krasnov GS; Pronina IV; Loginov VI; Kondratieva TT; Kazubskaya TP; Braga EA; Yenamandra SP; Ignatjev I; Ernberg I; Klein G; Lerman MI; Zabarovsky ER
Epigenetics; 2012 May; 7(5):502-13. PubMed ID: 22491060
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of tumor suppressor gene deletion between squamous cell carcinoma and adenocarcinoma lung cancer in Chinese].
An Q; Liu Y; Huang J
Zhonghua Zhong Liu Za Zhi; 2001 Nov; 23(6):470-2. PubMed ID: 11859712
[TBL] [Abstract][Full Text] [Related]
19. Differential Expression Pattern of THBS1 and THBS2 in Lung Cancer: Clinical Outcome and a Systematic-Analysis of Microarray Databases.
Weng TY; Wang CY; Hung YH; Chen WC; Chen YL; Lai MD
PLoS One; 2016; 11(8):e0161007. PubMed ID: 27513329
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity of the Mutated in Colorectal Cancer gene is not associated with promoter methylation in non-small cell lung cancer.
Poursoltan P; Currey N; Pangon L; van Kralingen C; Selinger CI; Mahar A; Cooper WA; Kennedy CW; McCaughan BC; Trent R; Kohonen-Corish MR
Lung Cancer; 2012 Aug; 77(2):272-6. PubMed ID: 22542170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
